Researchers compared injections to laser to laser+injections for diabetic maculopathy. At 24 months, the Ranibizumab group had slightly better mean vision, but in other ways, was slightly less better off than the laser+injection group. Considering that…
Lab Notes: Video Games May Aid Lazy Eye Recovery
(MedPage Today) — Energizing lazy eyes, how BPA affects human reproduction, immunizing against UTI, and promising but early studies in rheumatology highlight this week’s Lab Notes.
Lab Notes: Video Games May Aid Lazy Eye Recovery
(MedPage Today) — Energizing lazy eyes, how BPA affects human reproduction, immunizing against UTI, and promising but early studies in rheumatology highlight this week’s Lab Notes.
Freedom Meditech announces clinical study results of I-SugarX non-invasive glucose monitoring system
Freedom Meditech, Inc., the developer of non-invasive, ophthalmic-based products to detect and manage diabetes, today announced results of a clinical study that showed a high correlation between low to high blood glucose levels and non-invasive glucose…
Otsuka Pharmaceutical Files For Regulatory Approval In Japan For Mucosta® Ophthalmic Suspension For Dry Eye
Otsuka Pharmaceutical Co., Ltd. announced it has applied for regulatory approval in Japan to manufacture and market Mucosta® (rebamipide) ophthalmic suspension for treatment of dry eye. Dry eye is a chronic condition of the corneal and conjunctival ep…
Merck And Partners Make Progress In Long-Term Commitment To End River Blindness
Public health officials at the 20th Inter-American Conference on Onchocerciasis in Antigua, Guatemala, confirmed that more than one-third of all Latin Americans who ran the risk of contracting river blindness (onchocerciasis), a leading cause of preven…